Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease
暂无分享,去创建一个
R. Albin | N. Bohnen | R. Koeppe | K. Frey | V. Kotagal | M. Kilbourn | M. Müller
[1] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[2] K. Fiedler,et al. Olfactory Impairment Predicts Brain Atrophy in Parkinson's Disease , 2009, The Journal of Neuroscience.
[3] H. Berendse,et al. Prevalence of smell loss in Parkinson's disease--a multicenter study. , 2009, Parkinsonism & related disorders.
[4] Latha Velayudhan,et al. Smell Identification Test as a Treatment Response Marker in Patients With Alzheimer Disease Receiving Donepezil , 2009, Journal of clinical psychopharmacology.
[5] T. Suhara,et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET , 2009, Neuroscience Research.
[6] David A Bennett,et al. Olfactory Impairment in Presymptomatic Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.
[7] G. Miller,et al. Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity , 2009, The Journal of Neuroscience.
[8] M. Martí-Nicolovius,et al. Muscarinic receptor blockade in ventral hippocampus and prelimbic cortex impairs memory for socially transmitted food preference , 2009, Hippocampus.
[9] A. Petrie,et al. Regional differences in the severity of Lewy body pathology across the olfactory cortex , 2009, Neuroscience Letters.
[10] D. Aarsland,et al. Cognitive impairment in incident, untreated Parkinson disease , 2009, Neurology.
[11] H. Berendse,et al. Extended testing across, not within, tasks raises diagnostic accuracy of smell testing in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[12] N. Bohnen,et al. Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity , 2008, Neuroscience Letters.
[13] H. Reichmann,et al. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease , 2008, Journal of Neurology.
[14] Hiroto Kuwabara,et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease , 2007, Journal of Neurology.
[15] Thomas A Cleland,et al. Cholinergic modulation in the olfactory bulb influences spontaneous olfactory discrimination in adult rats , 2006, The European journal of neuroscience.
[16] D A Bennett,et al. The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[17] J. Langston,et al. The parkinson's complex: Parkinsonism is just the tip of the iceberg , 2006, Annals of neurology.
[18] Qing X. Yang,et al. Functional magnetic resonance imaging study of human olfaction and normal aging. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[19] Bruce Gordon,et al. Test Review: Wechsler, D. (2002). The Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III). San Antonio, TX: The Psychological Corporation , 2004 .
[20] Zhen Yan,et al. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid. , 2004, Current Alzheimer research.
[21] Lars-Göran Nilsson,et al. Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. , 2004, Chemical senses.
[22] N. Bohnen,et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. , 2003, Archives of neurology.
[23] D. Kareken,et al. Functional anatomy of human odor sensation, discrimination, and identification in health and aging. , 2003, Neuropsychology.
[24] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[25] Hansjürgen Bratzke,et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages) , 2002, Journal of Neurology.
[26] H. Eichenbaum,et al. Selective lesions of basal forebrain cholinergic neurons produce anterograde and retrograde deficits in a social transmission of food preference task in rats , 2002, The European journal of neuroscience.
[27] Donald A. Wilson,et al. Experience Modifies Olfactory Acuity: Acetylcholine-Dependent Learning Decreases Behavioral Generalization between Similar Odorants , 2002, The Journal of Neuroscience.
[28] Hitoshi Shinotoh,et al. Kinetic Analysis of [11C]MP4A Using a High-Radioactivity Brain Region That Represents an Integrated Input Function for Measurement of Cerebral Acetylcholinesterase Activity without Arterial Blood Sampling , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] Päivi Marjamäki,et al. Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment , 2001, Acta Neuropathologica.
[30] M. Hasselmo,et al. Contribution of the cholinergic basal forebrain to proactive interference from stored odor memories during associative learning in rats. , 2001, Behavioral neuroscience.
[31] H. Berendse,et al. Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis , 2001, Movement disorders : official journal of the Movement Disorder Society.
[32] S. Boelen,et al. Evaluation of a neck-shield for use during neurological studies with a whole-body PET scanner , 2000, 2000 IEEE Nuclear Science Symposium. Conference Record (Cat. No.00CH37149).
[33] M. Hasselmo,et al. Neural activity in the horizontal limb of the diagonal band of Broca can be modulated by electrical stimulation of the olfactory bulb and cortex in rats , 2000, Neuroscience Letters.
[34] D E Kuhl,et al. Assessment of Extrastriatal Vesicular Monoamine Transporter Binding Site Density Using Stereoisomers of [11C]Dihydrotetrabenazine , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] S Tanada,et al. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy , 1999, Annals of neurology.
[36] D. Kuhl,et al. Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. , 1998, Nuclear medicine and biology.
[37] R. Doty,et al. Physostigmine Enhances Performance on an Odor Mixture Discrimination Test , 1998, Physiology & Behavior.
[38] D E Kuhl,et al. Equilibrium versus Compartmental Analysis for Assessment of the Vesicular Monoamine Transporter Using (+)-α-[11C]Dihydrotetrabenazine (DTBZ) and Positron Emission Tomography , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] M R Kilbourn,et al. A simple synthesis of [11C]dihydrotetrabenazine (DTBZ). , 1997, Nuclear medicine and biology.
[40] J. McKenzie,et al. Lesions in the magnocellular preoptic nucleus decrease olfactory investigation in rats , 1996, Behavioural Brain Research.
[41] S. Minoshima,et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease , 1996, Annals of neurology.
[42] C. Geula,et al. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. , 1996, Cerebral cortex.
[43] D. Kuhl,et al. [3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity , 1995, Neuroscience.
[44] R. Doty,et al. Tests of human olfactory function: Principal components analysis suggests that most measure a common source of variance , 1994, Perception & psychophysics.
[45] N. Ravel,et al. Scopolamine injection into the olfactory bulb impairs short-term olfactory memory in rats. , 1994, Behavioral neuroscience.
[46] J. McKenzie,et al. Effects of lesions in the horizontal diagonal band nucleus on olfactory habituation in the rat , 1993, Neuroscience.
[47] C. Geula,et al. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease , 1993, The Journal of comparative neurology.
[48] S. Lehéricy,et al. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease , 1993, The Journal of comparative neurology.
[49] F. Roman,et al. Learning and memory of odor-reward association: selective impairment following horizontal diagonal band lesions. , 1993, Behavioral neuroscience.
[50] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[51] M. Serby,et al. The nature and course of olfactory deficits in Alzheimer's disease. , 1991, The American journal of psychiatry.
[52] David P. Salmon,et al. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease , 1990, Neurobiology of Aging.
[53] Richard L. Doty,et al. Presence of both odor identification and detection deficits in alzheimer's disease , 1987, Brain Research Bulletin.
[54] Y. Agid,et al. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease , 1986, Brain Research.
[55] E. Perry,et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[56] R. Doty,et al. Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.
[57] W. Thurlbeck. Accuracy of clinical diagnosis , 1982 .
[58] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[59] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[60] E. Fünfgeld,et al. Zur pathologischen Anatomie der Paralysis agitans , 1923 .
[61] P. S. Achilles. THE PSYCHOLOGICAL CORPORATION. , 1923, Science.
[62] R. Moriyasu. Zur pathologischen Anatomie der Paralysis agitans , 1908, Archiv für Psychiatrie und Nervenkrankheiten.
[63] J. Winn,et al. Brain , 1878, The Lancet.
[64] N. Ravel,et al. Scopolamine impairs delayed matching in an olfactory task in rats , 2005, Psychopharmacology.
[65] A. Hunter,et al. Cholinergic mechanisms in a simple test of olfactory learning in the rat , 2004, Psychopharmacology.
[66] J. Ridley. Studies of Interference in Serial Verbal Reactions , 2001 .
[67] M. Baxter,et al. Cholinergic basal forebrain is critical for social transmission of food preferences , 2000, Hippocampus.
[68] P. Moberg,et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. , 1998, Archives of neurology.
[69] M. Mintun,et al. Integrated and automated data analysis method for neuronal activation studies using O-15 water PET , 1993 .
[70] N. Bohnen,et al. Modification of the stroop color word test improves differentiation between patients with mild head injury and matched controls. , 1992, The Clinical neuropsychologist.
[71] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[72] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[73] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[74] P N Karnauchow,et al. Accuracy of clinical diagnosis. , 1982, Canadian Medical Association journal.